155R.A. Norman, J. Endo, Clinical Cases in Geriatric Dermatology, Clinical Cases in Dermatology,DOI 10.1007/978-1-4471-4135-8, © Springer-Verlag London 2013
Index
AAcneiform rash
biopsy, 134cetuximab, EGFR, 132–133diagnosis, 131patient history, 131–134treatment, 134–135
Acne vulgaris, 109AGA. See Androgenetic
alopeciaAlopecia areata, 148American Joint
Committee on Cancer (AJCC), 86
Anaplastic large cell lymphoma (stage IIE)
cause of, 52diagnosis, 51, 53NHL, 52patient history, 51, 52symptoms, 52treatment, 53
Androgenetic alopecia (AGA)
diagnosis, 146differential diagnoses, 148pathophysiology, 147patient history, 145, 146risk marker, 147treatment, 147
Angioedema, 139
Angiosarcomadiagnosis, 47lymphedema-related
vs. non-lymphedema- related, 48
patient history, 47, 48prognostic factor, 49treatment, 48–49
Annular sarcoidosis, 122Atrophie blanche, 127Atypical fibroxanthoma
diagnosis, 56–57epidemiologic evidence, 56low-grade sarcoma, 56patient history, 55, 56treatment, 57
BBasal cell carcinoma, 119
diagnosis, 73patient history, 73, 74symptoms, 73–74treatment, 74
B-cell non-Hodgkins lymphomas, 53
Bowen’s disease, 40Breast metastasis
diagnosis, 77patient history, 77, 78surgery and chemotherapy, 78
156 Index
Brittle nailsdiagnosis, 151nutritional deficiencies, 152pathophysiology, 152patient history, 151, 152treatment, 153
Bullous pemphigoidclinical appearance, 5diagnosis, 4immunoblistering disease, 4patient history, 3–4skin biopsy, 97urticarial phase, 139
Bullous scabies, 6
CCandidiasis
Candida albicans, 42cutaneous fungal infections, 42diagnosis, 41irritant intertrigo, 43paronychia, 42patient history, 41, 42symptoms, 43thrush, 42treatment, 43
Cellulitis, 44Centers for Disease Control
(CDC), 30Condyloma accuminata
diagnosis, 37gardasil, 40patient history, 37–39preventive/treatment measures,
38–39warts, HPV, 37–39
Condylomata lata of secondary syphilis, 40
Contact dermatitis, 78allergic and irritant causes, 96degree of vesiculation, 96diagnosis, 95history and skin
examination, 97lichenification and crusting, 119patch testing, 97
patient history, 95, 96risk factor, 97treatment, 97venous stasis (gravitational)
ulcer, 126Cutaneous T-Cell lymphoma
(CTCL), 68
DDisseminated superficial actinic
porokeratosis (DSAP), 122
EEczema, 44, 64Epidermolysis bullosa acquisita
(EBA), 5–6Erythema annulare
centrifugum, 123Erythema multiforme, 139Erythema nodosum, 10
FFibrosarcoma, 49Fixed drug eruption, 82
GGiant cell tumor, tendon sheath
diagnosis, 90localized and diffuse types, 91patient history, 89, 90skin biopsy, 89, 91texture, 90treatment, 91
Gougerot-Blum disease, 115Granuloma annulare, 122
HHair transplant, 148Herpes zoster
diagnosis, 27immunocompromised patient
considerations, 30
157Index
multiple contiguous/ noncontiguous dermatomes, 28
patient history, 27–29postherpetic neuralgia, 28risk factors, 28varicella zoster virus, 27
Human papilloma virus (HPV), 37–39
Hypertensive (arterial) ulcers, 126–127
IIchthyosis vulgaris, 101Immunoblistering disease, 4Impetigo, 79Infectious ulcers, 127Inflammatory ulcers, 127Intertriginous candidiasis, 43
KKeratosis pilaris, 109
LLentigo maligna
diagnosis, 81patient history, 81, 82slow-growing variant, 82symptoms, 81–82treatment, 82
Lichen aureus, 115Lichen planus, 40Lupus erythematosus, 109
MMajocchi’s disease, 114Malignant melanoma, 49Mal perforans, 127Mammary Paget’s disease
cytopathology, 64diagnosis, 63, 64mammogram
and biopsy, 64
patient history, 63, 64treatment, 65
Median nail dystrophy, 153Merkel cell carcinoma, stage I
diagnosis, 59Mohs surgery, 60patient history, 59, 60polyomavirus, 60prognosis, 60treatment algorithm, 60
Metastatic carcinoma, 53Mycosis fungoides (MF)
CTCL, 68diagnosis, 67, 69erythrodermic stage, 69pathogenesis, 68patient history, 67–70prognosis, 69treatment, 69–70tumor stage, 68–69
NNeoplastic ulcers, 127Non-Hodgkin lymphoma
(NHL), 52Nummular dermatitis, 100
OOnychomycosis, 153
PPalmoplantar pustulosis, 104Pemphigus vulgaris, 5Pigmented basal cell carcinoma, 83Pigmented villonodular synovitis
(PVNS), 91Polyarteritis nodosa
causes, 10diagnosis, 9patient history, 9ulcerations, 10
Porokeratosisdiagnosis, 121DSAP, 122
158 Index
Porokeratosis (cont.)keratinization, benign clonal
disorder, 122patient history, 121, 122treatment, 122
Post-inflammatory hyperpigmentation, 82–83
Pressure necrosis, 78Prurigo nodularis
butterfly sign, 118diagnosis, 117patient history, 117, 118treatment, 118
Psoriasis, 35, 44diagnosis, 103palmoplantar pustulosis, 104patient history, 103, 104pustular, 105sebopsoriasis, 104treatment, 105
Psoriatic nail disease, 153Pterygium, 153Pustular psoriasis, 97PVNS. See Pigmented
villonodular synovitisPyoderma gangrenosum
causes, 14diagnosis, 13patient history, 13, 14periulcer erythema, 10
Pyogenic granuloma, 49
RRheumathoid vasculitis, 14Rhinophyma, 108Rosacea
causes, 108diagnosis, 108erythematotelangiectatic
type, 108papulopustular type, 108patient history, 107, 108psychological
conditions, 108treatments, 109
SScabies
clinical examination, 24diagnosis, 23, 24mupirocin/oral
anti-infectives, 25oral antihistamines, 25oral ivermectin, 25patient history, 23, 24permethrin, 25pruritus, 25risk factors, 24Sarcoptes scabiei mite, 23skin scraping, 119topical/oral
glucocortiocsteroids, 25treatment, 24–25
SCC. See Squamous cell carcinomaSchamberg’s disease
diagnosis, 111patient history, 111–114purpuric dermatosis, 114
SCLE. See Subacute cutaneous lupus erythematosus
Sebopsoriasis, 104Seborrheic dermatitis, 109Shingles. See Herpes zosterSmall plaque parapsoriasis, 35Solar lentigo, 82Squamous cell carcinoma (SCC),
14, 119appearance, 86diagnosis, 85–87patient history, 85, 86risk factor, 86sun-exposed skin areas, 86treatment, 87
Stasis dermatitis, 101, 115Subacute cutaneous lupus
erythematosus (SCLE)antinuclear antibodies, 18diagnosis, 17drug-induced lupus, 18patient history, 17, 18topical steroids and
antimalarials, 19
159Index
Superficial thrombophlebitis, 10Syphilis, 148
TTelogen effluvium, 148Tinea corporis, 35, 44, 79, 122Tinea manuum, 97Tinea versicolor
diagnosis, 33, 34location, 34Malassezia furfur, 34patient history, 33–35treatment, 34–35
Traumatic/factitial ulcers, 127Trichotillomania, 148
UUrticaria
allergic/nonallergic mast cell degranulation, 138
biopsy, 138causes, 138diagnosis, 137patient history, 137–139
peripheral blanching and dermographism, 137
prognosis, 140treatment, 139–140
Urticarial vasculitis, 139
VVenous stasis
(gravitational) ulcercontact dermatitis, 126diagnosis, 125etiology, 126panniculitis, 126patient history, 125, 126
Vitiligo, 35
XXerosis
“crazy pavement” appearance, 99
diagnosis, 99patient history, 99, 100prognosis, 102treatment, 101